Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK -rearranged non-small cell lung cancer Source: Eur Respir J, 51 (5) 1702431; 10.1183/13993003.02431-2017 Year: 2018
Lazarus syndrome in nonsmall cell lung cancer patients with poor performance status and major leukocytosis following nivolumab treatment Source: Eur Respir J, 50 (1) 1700310; 10.1183/13993003.00310-2017 Year: 2017
Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021
Symptoms, signs and staging of lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=86 Year: 2001
Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
Study on coagulation abnormality and effect of anticoagulation on prognosis in advanced cases of non-small cell lung cancer Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008
Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer? Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018
Age and stage at presentation in lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005
The diagnostic value of serum tumor markers in newly diagnosed lung cancer patients Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017
Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018 Year: 2019
Prognostic value of comorbidity in operated non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006
The predictive value of neuroendocrine markers for response to chemotherapy and survival in patients with non-small cell lung Source: Eur Respir J 2006; 28: Suppl. 50, 386s Year: 2006
The prognostic value of the expression of GST-π in response to chemotherapy in cytological and pathological specimens of patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 74s Year: 2002
Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy Source: Eur Respir Rev 2013; 22: 565-576 Year: 2013
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012
The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016
Prognostic factors affecting survival in advanced non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004
FDG-PET SUVmax is an independent prognostic indicator in patients with non-small cell lung cancer Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011
Effects of prognostic factors on survival of the patients of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 326s Year: 2005
Symptoms and signs of lung cancer Source: Eur Respir Mon; 2009: 44: 71–87 Year: 2009